Therapeutic Area | MeSH |
---|---|
hemic and lymphatic diseases | D006425 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neutropenia | D009503 | — | D70 | — | 1 | 3 | — | — | 3 |
Chemotherapy-induced febrile neutropenia | D064146 | — | — | — | 1 | 2 | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | — | 1 | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | — | — | 1 | — | — | 1 |
B-cell lymphoma | D016393 | — | — | — | — | 1 | — | — | 1 |
Aggression | D000374 | EFO_0003015 | — | — | — | 1 | — | — | 1 |
Drug common name | Lipegfilgrastim |
INN | lipegfilgrastim |
Description | Lipegfilgrastim, sold under the brand name Lonquex, is a medication used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adults. It is given by injection under the skin in the abdomen, upper arm or thigh.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF); PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 1117844-87-7 |
RxCUI | 1440046 |
ChEMBL ID | CHEMBL4594230 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB13200 |
UNII ID | 4AWF0N6QV3 (ChemIDplus, GSRS) |